Bladder cancer treatment and methods
OwnerDorla Mirejovsky, Guru Reddy +1inventors
InventorsDorla Mirejovsky, Guru Reddy, Luigi Lenaz
Life of this patent
Estimating the term…
Abstract
Disclosed herein are various bladder cancer treatments and methods. The present disclosure can take advantage of propylene glycol concentrations and/or NAD(P)H:quinone oxidoreductase-1 (NQO1), Cytochrome P450 Oxidoreductase (P450R) and Glucose transporter 1 (Glut-1) protein expression in human transitional cell carcinoma of the bladder to offer individually targeted bladder cancer treatments.
Claims24
A pharmaceutical preparation comprising EO9 in a solution with a propylene glycol (PG) concentration selected from the group consisting of about 30% vol/vol PG, about 20% vol/vol PG, and about 10% vol/vol PG.
A pharmaceutical preparation comprising EO9, NaHCO3 and mannitol in a solution comprising PG, EDTA and water wherein said PG is present in said solution in a percentage range selected from the group consisting of about 6% to about 14% vol/vol;
- about 16% to about 24% vol/vol, and about 26% to about 34% vol/vol.
Dependencies are inferred from the claim text.